Navigation Links
CTCs predict poor outcome from blood stem cell transplantation therapy for metastatic breast cancer
Date:12/10/2010

SAN ANTONIO Metastatic breast cancer patients who had circulating tumor cells (CTCs) in their blood before or after high-dose chemotherapy (HDCT) followed by autologous stem cell transplantation had poor outcomes, according to researchers from the University of Texas MD Anderson Cancer Center.

Patients with CTCs in their blood before chemotherapy treatment had reduced survival and those with these cells in their blood after the stem cell transplant recurred faster and died earlier. These findings were presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held Dec 8-12.

While it has been known that CTCs in metastatic breast cancer are linked to cancer recurrence and lower survival, this study adds several new insights, the researchers said. One is that the process of collecting hematopoietic progenitor cells appears to recruit CTCs from bone marrow into the blood, and the other is that these CTCs are likely to be responsible for cancer recurrence.

"Our group had previously shown that metastatic breast cancer patients with CTCs in their blood relapsed faster and now we see that these same cells can be recruited from bone marrow and that they may have the same effect on disease outcome," said the lead researcher Hui Gao, Ph.D., a research scientist working in the laboratory of James M. Reuben, Ph.D.

"Furthermore, some CTCs seem to have the characteristic markings of stem-like cells, but we don't know yet if they are cancer stem cells," Gao said.

The 21 patients included in this study were younger women (average age of 44) diagnosed with metastatic breast cancer who were offered high-dose chemotherapy followed by stem cell transplant. Before chemotherapy, patients were given a growth factor treatment to recruit hematopoietic progenitor cells from bone marrow, then the cells were harvested from their blood.

CTCs were found in six patients before transplant and in nine patients one month after. Researchers determined that more than five CTCs at baseline was associated with shorter overall survival and that five or more CTCs after transplant was linked to both shorter relapse-free survival and overall survival.

The process of using growth factors to mobilize hematopoietic stem cells also appears to mobilize some CTCs that have lost their epithelial properties and undergo mesenchymal transition, according to the researchers. Such cells are not easily detected by the conventional CTC detection assays and the importance of this observation might be overlooked by the clinicians.

High-dose chemotherapy followed by stem cell transplant did reduce the number of existing CTCs in some patients, but increased CTCs in other patients. Patients who recurred faster and had shorter survival had a higher percentage of epithelial cells with stem-like markings mixed in with blood hematopietic progenitor cells that were mobilized by the growth factor to enter blood stream.

"When we enriched for hematopoietic progenitor cells, we found some CTCs within the milieu of cells we collected," Gao said.

In some cases, mobilization may have facilitated the release of cancer stem cells from the bone marrow that were associated with shorter relapse-free survival. However, mobilized CTCs can be removed from the final transplanted product using a procedure to positively select for CD34+ hematopoietic progenitor cells. This procedure may account for the fact that the patients with low CTCs did well.


'/>"/>

Contact: Jeremy Moore
jeremy.moore@aacr.org
267-646-0557
American Association for Cancer Research
Source:Eurekalert

Related medicine news :

1. Early life stress may predict cardiovascular disease
2. SIBLING proteins may predict oral cancer
3. Researchers receive NIH grant to study predictors and outcomes of autoimmune lung disease
4. Fatigue May Predict Heart Attack in Dialysis Patients
5. Predicted Red Tide Could Make Shellfish a Dangerous Dish
6. New tool to predict early death or hospital readmission
7. MSU scientists develop more effective method of predicting lead-poisoning risk
8. Newer Blood Test Predicts Diabetes, Heart Disease
9. Proteins May Predict Spread of Colon Cancer
10. After a fight with a partner, brain activity predicts emotional resiliency
11. Study Predicts Half of Physician Continuing Education Will Be Online by 2016
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... , ... While it’s often important to take certain medications during the night, ... has identified a solution. , She developed a prototype for MOTION LIGHT-UP PILL BOX ... eliminates the need to turn on a light when taking medication during the night, ...
(Date:10/13/2017)... (PRWEB) , ... October 13, ... ... School of Pharmacy (SOP) alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, ... professionals on guideline updates for the primary prevention of cardiovascular diseases during ...
(Date:10/13/2017)... ... ... The Visiting Nurse Association (VNA) of Somerset Hills is proud to host ... items from across the nation, this holiday-themed event will raise funds and awareness for ... The boutique will be open Saturday, November 4 (10:00 a.m. – 5:00 p.m.) ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, ... lowdown on sciatica in a new episode of "Success Files," which is an ... and innovation and investigates each subject in-depth with passion and integrity. , Sciatica ...
(Date:10/12/2017)... WILMINGTON, Del. (PRWEB) , ... October 12, 2017 ... ... technology and advisory services for healthcare compliance program management, will showcase a range ... and National Association for Assisted Living (NCAL) Convention and Expo to be held ...
Breaking Medicine News(10 mins):
(Date:10/5/2017)... , Oct. 5, 2017  In response ... of Oral and Maxillofacial Surgeons (AAOMS) released prescribing ... – to be used as a first-line therapy ... Recognizing the ... AAOMS White Paper "Opioid Prescribing: Acute and Postoperative ...
(Date:10/2/2017)... 2, 2017  Eli Lilly and Company (NYSE: ... the third quarter of 2017 on Tuesday, October 24, ... that day with the investment community and media to ... conference call will begin at 9 a.m. Eastern time. ... live webcast of the conference call through a link ...
(Date:9/28/2017)... 28, 2017 Cohen Veterans Bioscience and Early ... of wearable and home sensors for real-time monitoring of ... Foundation, a nonprofit organization focused on disruptive health solutions ... affordable analytical system to record and integrate behavioral, cognitive, ... ...
Breaking Medicine Technology: